You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

enzyme replacement therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gaucher Disease Type 1 Trial in Jerusalem (Enzyme replacement therapy for Gaucher disease in combination with altus care

Completed
  • Gaucher Disease Type 1
  • Enzyme replacement therapy for Gaucher disease in combination with altus care application
  • Jerusalem, Israel
    Hebrew university
Sep 18, 2023

Fabry Disease Under Enzyme Replacement Therapy With

Recruiting
  • Fabry Disease
  • Berlin, Germany
  • +7 more
Oct 17, 2023

Sphingomyelin Lipidosis Trial (olipudase alfa (GZ402665))

Approved for marketing
  • Sphingomyelin Lipidosis
  • olipudase alfa (GZ402665)
  • (no location specified)
Sep 15, 2022

Gaucher Disease, Type 3 Trial (Gene therapy, Enzyme Replacement Agent)

Not yet recruiting
  • Gaucher Disease, Type 3
  • Gene therapy
  • Enzyme Replacement Agent
  • (no location specified)
Apr 14, 2023

Acute Pancreatitis, Exocrine Pancreatic Insufficiency, Gut Microbiota Trial in Coimbra (Pancreatic Enzyme Replacement Therapy,

Recruiting
  • Acute Pancreatitis
  • +3 more
  • Pancreatic Enzyme Replacement Therapy
  • Placebo
  • Coimbra, Portugal
    Centro Hospitalar e Universitário de Coimbra, E.P.E.
Jul 27, 2022

Pancreatic Exocrine Insufficiency, Pancreatic Enzyme Replacement Therapy, Pancreaticoduodenectomy Trial in Shanghai (Pancreatin

Recruiting
  • Pancreatic Exocrine Insufficiency
  • +2 more
  • Pancreatin Enteric-coated Capsules
  • Routine treatment plan
  • Shanghai, Shanghai, China
    Shanghai Ruijin Hospital
Nov 1, 2023

Gaucher Disease, Type 1 Trial in Jerusalem (Ambroxol)

Active, not recruiting
  • Gaucher Disease, Type 1
  • Jerusalem, Israel
    Shaare Zedek Medical Center
May 24, 2022

ERT in Pompe Disease: Elucidation of Molecular Structures

Not yet recruiting
  • Pompe-Disease
    • Rüsselsheim, Hessen, Germany
      Centre for Analytical Biochemistry
    Jan 30, 2023

    Fabry Disease Trial in Taipei

    Recruiting
    • Fabry Disease
      • Taipei, Taiwan
        Investigational Site Number :1580001
      Sep 24, 2023

      MPS II Immunophenotyping

      Recruiting
      • MPS II
      • +2 more
        • Durham, North Carolina
          Duke University
        Jun 3, 2022

        MPS I, MPS II, MPS IVA Trial in San Francisco (Aldurazyme (laronidase))

        Recruiting
        • MPS I
        • +8 more
        • Aldurazyme (laronidase)
        • San Francisco, California
          University of California
        Apr 21, 2022

        Both Patients and Their Clinicians in Treatment of Fabry Disease

        Completed
        • Fabry Disease
        • Agalsidase Beta
        • Agalsidase Alpha
        • Philadelphia, Pennsylvania
        • +8 more
        Oct 27, 2022

        Unresectable Pancreatic Cancer Trial (creon 35.000 Ph.U (R), Best Standarard of Care)

        Not yet recruiting
        • Unresectable Pancreatic Cancer
        • creon 35.000 Ph.U (R)
        • Best Standarard of Care
        • (no location specified)
        Oct 19, 2023

        Mucopolysaccharidosis I Trial in Wuhan (Laronidase)

        Recruiting
        • Mucopolysaccharidosis I
        • Wuhan, China
          Investigational Site Number :1560001
        Jan 15, 2023

        Mucopolysaccharidosis Trial in Gaziantep (Enzyme Replacement Agent)

        Completed
        • Mucopolysaccharidosis
        • Enzyme Replacement Agent
        • Gaziantep, None Selected, Turkey
          Serkan Usgu
        Aug 7, 2021

        Velaglucerase Alfa Given as Standard Patient Care in Young

        Recruiting
        • Gaucher Disease
        • Standard of Care
        • Fairfax, Virginia
          Lysosomal & Rare Disorders Research & Treatment Center
        Jan 5, 2023

        Pompe Disease (Late-onset) Trial in Durham (Clenbuterol, Placebos)

        Withdrawn
        • Pompe Disease (Late-onset)
        • Durham, North Carolina
          Duke University Medical Center
        Aug 15, 2022

        Patients With Juvenile-onset Pompe Disease

        Recruiting
        • Pompe's Disease Juvenile Onset
          • Nancy, France
            Children's Hospital - CHRU de Nancy
          Jul 2, 2021

          Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

          Recruiting
          • Metastatic Pancreatic Ductal Adenocarcinoma
          • +12 more
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          Nov 30, 2022

          Fabry's Disease Trial in China (Agalsidase beta)

          Active, not recruiting
          • Fabry's Disease
          • Agalsidase beta
          • Beijing, China
          • +5 more
          May 4, 2022

          Pancreatic Adenocarcinoma Trial in Los Angeles (Pancrelipase)

          Recruiting
          • Pancreatic Adenocarcinoma
          • Los Angeles, California
            Cedars-Sinai Medical Center
          Jul 15, 2022

          Pancreatic Insufficiency Trial in Canada (PERT at discharge, Standard of Care)

          Not yet recruiting
          • Pancreatic Insufficiency
          • PERT at discharge
          • Standard of Care
          • Hamilton, Ontario, Canada
          • +5 more
          Jul 18, 2022

          Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal

          Recruiting
          • Fabry Disease
            • Minneapolis, Minnesota
            • +1 more
            Sep 16, 2022

            Mucopolysaccharidosis II Trial in Worldwide (Iduronate-2-sulfatase enzyme replacement therapy, iduronate-2-sulfatase enzyme

            Completed
            Has Results
            • Mucopolysaccharidosis II
            • Iduronate-2-sulfatase enzyme replacement therapy
            • +2 more
            • Oakland, California
            • +8 more
            May 30, 2021

            Gaucher Disease Trial in Hamamatsu, Minato-ku, Osaka (velaglucerase alfa)

            Completed
            Has Results
            • Gaucher Disease
            • velaglucerase alfa
            • Hamamatsu, Shizuoka, Japan
            • +2 more
            Jun 25, 2021